STOCK OPTIONS

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

STOCK OPTIONS

NOTE 9 - STOCK OPTIONS

On June 21, 2021, the board of directors of the Company approved the 2021 Equity Incentive Plan (the “2021 Plan”) pursuant to which the Company may issue awards, from time to time, consisting of non-qualified stock options, restricted stock grants and restricted stock units. In addition, stock option awards that qualify under Section 102 of the Israeli Tax Ordinance (New Version) 1961 (the “ITO”), and/or under Section 3(i) of the ITO, may be granted.

On June 28, 2021, the Board of Directors of the Company approved the issuance of options to purchase 6,800,000,000 shares of the Company’s Common Stock with an exercise price of $0.0001, to three members of its advisory board, under the Company’s 2021 Plan. Options to purchase 1,700,000,000 shares of Common Stock shall vest on the first anniversary of the agreement and the remaining options shall vest quarterly, over additional 3 years. The grant is subject the approval of the Board of Directors of the Company.

The fair value of the options was determined using the Black-Scholes pricing model, assuming a risk free rate of 0.27%, a volatility factor of 342%, dividend yields of 0% and an expected life of 4 years and was estimated at $5,436,000.

The following table presents the Company’s stock option activity during the year ended December 31, 2021:

	Number of Options		Weighted Average Exercise Price
Outstanding at December 31,2020		-		-
Granted		6,800,000,000		0.0001
Exercised		-		-
Forfeited or expired		-		-
Outstanding at December 31, 2021		6,800,000,000		0.0001
Number of options exercisable at December 31, 2021		-		-

The aggregate intrinsic value of the awards outstanding as of December 31, 2021 is $2,720,000. These amounts represent the total intrinsic value, based on the Company’s stock price of $0.0005 as of December 31, 2021, less the weighted exercise price. This represents the potential amount received by the option holders had all option holders exercised their options as of that date.

WORLD HEALTH ENERGY HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(U.S. dollars except share and per share data)

NOTE 9 - STOCK OPTIONS (continue)

The stock options outstanding as of December 31, 2021, have been separated into exercise prices, as follows:

Exercise price	Stock options outstanding		Weighted average remaining contractual life – years		Stock options vested
As of December 31, 2021
0.0001		6,800,000,000		3.49		-
0.001		6,800,000,000		3.49		-

Compensation expense recorded by the Company in respect of its stock-based compensation awards for the year ended December 31, 2021 was $2,084,121 and are included in General and Administrative expenses in the Statements of Operations.